References
1. Gearhart P.J., Mock B.A., Casellas R., Cancro M.P. The reign of antibodies: A celebration of and tribute to Michael Potter and his homogeneous immunoglobulin workshops. J. Immunol. 2018; 200: 23–6. DOI: https://www.doi.org/10.4049/jimmunol.1701516.
2. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256: 495–7. DOI: https://www.doi.org/10.1038/256495a0.
3. Küppers R. B cells under influence: transformation of B cells by Epstein–Barr virus. Nat. Rev. Immunol. 2003; 3: 801–2. DOI: https://www.doi.org/10.1038/nri1201.
4. Nilsson K. Human B-lymphoid cell lines. Hum. Cell. 1992; 5: 25–41. PMID: 1329931.
5. Crain M.J., Sanders S.K., Butler J.L., Cooper M.D. Epstein-Barr virus preferentially induces proliferation of primed B cells. J. Immunol. 1989; 143: 1543–8. PMID: 2547870.
6. Laffly E., Sodoyer R. Monoclonal and recombinant antibodies, 30 years after. Hum. Antibodies. 2005; 14: 33–55. PMID: 16424599.
7. O’Nions J., Allday M.J. Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein–Barr virus or T cell-derived mitogens. J. Gen. Virol. 2004; 85: 881–95. DOI: https://www.doi.org/10.1099/vir.0.19704-0.
8. Steinitz M. Production of human monoclonal antibodies by the Epstein–Barr virus method. In: Steinitz M. (ed). Methods Mol. Biol. Humana Press: Totowa, N.J. 2014; 1060: 111–22. DOI: https://www.doi.org/10.1007/978-1-62703-586-6_6.
9. Mossalayi M.D., Lecron J.C., Tanzer J., Goube de Laforest P. Relationship between IL-2 and human T cell colony formation. Clin. Exp. Immunol. 1986; 66: 532–8. PMID: 3494553.
10. Rohaan M.W., van den Berg J.H., Kvistborg P., Haanen J.B.A.G. Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option. J. Immunother. Cancer. 2018; 6: 102. DOI: https://www.doi.org/10.1186/s40425-018-0391-1.
11. Auladell M., Nguyen T.H., Garcillán B., Mackay F., Kedzierska K., Fox A. Distinguishing naïve-from memory-derived human B cells during acute responses. Clin. Transl. Immunol. 2019; 8. DOI: https://www.doi.org/10.1002/cti2.1090.
12. Banchereau J., Bazan F., Blanchard D., Briè F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994; 12: 881–926. DOI: https://www.doi.org/10.1146/annurev.iy.12.040194.004313.
13. Huggins J., Pellegrin T., Felgar R.E., Wei C., Brown M., Zheng B., Milner E.C.B., Bernstein S.H., Sanz I., Zand M.S. CpG DNA activation and plasma-cell differentiation of CD27− naive human B cells. Blood. 2007; 109: 1611–9. DOI: https://www.doi.org/10.1182/blood-2006-03-008441.
14. Wiesner M., Zentz C., Mayr C., Wimmer R., Hammerschmidt W., Zeidler R., Moosmann A. Conditional immortalization of human B cells by CD40 ligation. PLoS ONE. 2008; 3: e1464. DOI: https://www.doi.org/10.1371/journal.pone.0001464.
15. Filatov A.V., Lavrova O.I., Mazurov D.V., Chevalier A.F. Expression of Lymphocyte Phosphatase-Associated Protein on human lymphoid lines. Immunologiya. 2011; 32 (1): 30–4. (in Russian)
16. Filatov A.V., Krotov G.I., Zgoda V.G., Volkov Y. Fluorescent immunoprecipitation analysis of cell surface proteins: A methodology compatible with mass-spectrometry. J. Immunol. Meth. 2007; 319: 21–33. DOI: https://www.doi.org/10.1016/j.jim.2006.09.014.
17. Khvastunova A.N., Kuznetsova S.A., Al-Radi L.S., Vylegzhanina A.V., Zakirova A.O., Fedyanina O.S., Filatov A.V., Vorobjev I.A., Ataullakhanov F. Anti-CD antibody microarray for human leukocyte morphology examination allows analyzing rare cell populations and suggesting preliminary diagnosis in leukemia. Sci. Rep. 2015; 5: 12573. DOI: https://www.doi.org/10.1038/srep12573.
18. Berg E.A., Fishman J.B. Labeling antibodies with Cy5-phycoerythrin. Cold Spring Harb. Protoc. 2019; pdb.prot099317. DOI: https://www.doi.org/10.1101/pdb.prot099317.
19. Vira S., Mekhedov E., Humphrey G., Blank P.S. Fluorescent-labeled antibodies: Balancing functionality and degree of labeling. Anal. Biochem. 2010; 402: 146–50. DOI: https://www.doi.org/10.1016/j.ab.2010.03.036.
20. Lushova A.A., Zheremyan E.A., Astakhova E.A., Spiridonova A.B., Byazrova M.G., Filatov A.V. B-lymphocyte subsets: functions and molecular markers. Immunologiya. 2019; 40 (6): 63–76. DOI: https://www.doi.org/10.24411/0206-4952-2019-16009. (in Russian)
21. Kwakkenbos M.J., Bakker A.Q., van Helden P.M., Wagner K., Yasuda E., Spits H., Beaumont T. Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire. Methods. 2014; 65: 38–43. DOI: https://www.doi.org/10.1016/j.ymeth.2013.07.002.
22. Kwakkenbos M.J., Diehl S.A., Yasuda E., Bakker A.Q., van Geelen C.M.M., Lukens M.V. van Bleek G.M., Widjojoatmodjo M.N., Bogers W.M.J.M., Mei H., Radbruch A., Scheeren F.A., Spits H., Beaumont T. Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming. Nat. Med. 2010; 16: 123–8. DOI: https://www.doi.org/10.1038/nm.2071.
23. Kwakkenbos M.J., Helden P.M., Beaumont T., Spits H. Stable long‐term cultures of self‐renewing B cells and their applications. Immunol. Rev. 2016; 270: 65–77. DOI: https://www.doi.org/10.1111/imr.12395.
24. Boldyreva M.N. SARS-CoV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors for the development of infections. Immunologiya. 2020; 41 (3): 197–205. DOI: https://www.doi.org/10.33029/0206-4952-2020-41-3-197-205. (in Russian)